相关实验视频
Updated: Jun 27, 2026
12:42
Isolation of Retinal Arterioles for Ex Vivo Cell Physiology Studies
Published on: July 14, 2018
10.3K
在体内向内皮KCa通道,恢复了2型糖尿病大鼠的动脉和内皮功能
Ramesh C Mishra1, Darrell D Belke2, Latika Singh3
1Dept. of Physiology and Pharmacology, Cumming School of Medicine and Libin Cardiovascular Institute, University of Calgary, Canada.
Metabolism: clinical and experimental
|August 20, 2024
概括
KCa通道激活剂SKA-31恢复了2型糖尿病大鼠的血管扩张,改善了内皮功能. 这项研究证明了SKA-31在糖尿病中治疗血管功能障碍的潜力.
科学领域:
- 心血管研究研究心血管研究
- 药理学 药理学是指药理学的学科.
- 内分泌学 在内分泌学.
背景情况:
- 2型糖尿病 (T2D) 与内皮功能障碍有关,影响血管扩张.
- 以前的研究表明,SKA-31从T2D模型中隔离的动脉中改善了血管扩张.
- 在T2D受试者的完整血管床中恢复血管扩张的SKA-31的体内疗效仍未得到研究.
研究的目的:
- 为了确定SKA-31的使用是否能在2型糖尿病大鼠体内恢复内皮依赖的血管扩张.
- 评估KCa通道激活对于糖尿病血管并发症的治疗潜力.
主要方法:
- 雄性Sprague Dawley (SD) 和2型糖尿病 (T2D) Goto-Kakizaki (GK) 鼠被用SKA-31或载体治疗.
- 多普勒超声波评估关动脉流介导扩张 (FMD) 在袖子释放后.
- 冠状动脉直径的变化在异黄素吸入期间被测量.
主要成果:
- 在对照SD大鼠中,SKA-31没有改变口病.
- 在T2D GK大鼠中,SKA-31显著恢复了受损的口炎到SD大鼠中的水平.
- 在T2D GK大鼠中,SKA-31治疗使冠状动脉扩张成为对异黄素的反应,与车载治疗不同.
结论:
- 在体内给予SKA-31有效地恢复T2D大鼠的内皮依赖血管扩张.
- 增强KCa通道活性代表了对2型糖尿病的外周内皮功能障碍的有前途的治疗策略.
相关概念视频
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...